The group of scientists at the University of Leicester (UK) has developed a medicine capable of reducing the negative consequences of heart attack and stroke up to 60%. The medicine prevents the death of heart and brain cells which have not received oxygen as a result of blood vessels blockage.
The research supervisor, Professor William Shvable, called the first 9-12 hours after a heart attack the most critical period when the body’s immune system launches special protective and repair mechanisms.
The scientists have found the way to neutralize it by means of injecting antibodies in order to prevent the body from rejecting the cells that for some time were deprived of oxygen.
The medicine has been tested on animals and with the use of human blood. The tests have demonstrated positive results. It is expected that the new medication will be available during the next two years.
Source of the image: Photl.
